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Alcohol is a psychoactive substance that can lead to significant organ damage if consumed 
chronically for long periods of time. The liver parenchyma is the main site of alcohol 
metabolism, and liver damage can be characterized through a spectrum of pathological 
conditions termed alcoholic liver disease (ALD). Alcoholic hepatitis (AH) is a late stage of ALD 
in which an immune response is mounted against the liver parenchyma, leading to poor 
prognosis and high mortality rates. Crosstalk between nonparenchymal liver cells has been 
shown to mediate both inflammation and wound healing responses: the liver’s resident 
macrophages, Kupffer cell’s, induce transdifferentiation in hepatic stellate cells towards a 
fibrogenic effector cell lineage. Transdifferentiation has been linked to increases in inhibitor of 
differentiation 1 (Id1) within hepatic stellate cells. Increases in Id1 are correlated with various 
models of liver injury, but whether this increase is observed in alcoholic liver injury has yet to be 
shown. We observed increased expression of Id1 in liver tissue samples from patients 
experiencing alcoholic hepatitis. Moreover, through western blot analysis of human donor, AH, 
and alcoholic cirrhosis liver tissue samples we showed the presence of a protein band in AH 
samples seen only sparsely in the other tissue samples. This protein band is closer to the 
predicted weight of Id1 which may suggest that the protein is undergoing an activating reaction: 
dephosphorylation or deubiquitination. We hypothesize that this increase in Id1 is linked to 
increased cellular oxidative stress brought about by the inflammatory response during alcoholic 
hepatitis. This information not only confirms increases in Id1 during alcoholic hepatic injury, but 
it also may shed light on a novel mechanism by which the liver protect itself against oxidative 
stress.  
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Fig. 1. Testing different Id1 antibodies to gauge differential expression in alcoholic hepatitis 
(AH, top row) and normal (N, bottom row) liver tissue. Abcam Id1 antibody stained both AH 
and N tissue to a similar degree which suggests non-specific binding of the antibody since 
literature consistently states low expression in normal tissue (A). Santa Cruz Id1 antibody-
stained AH tissue to a higher degree than normal tissue which suggests more specific binding 
(B). IgG2a isotype of Id1 antibody used on both tissues as a positive control to demonstrate that 

















Fig. 2. Santa Cruz anti-Id1 staining on multiple AH (top) and N (bottom) tissue samples. Visibly 















Fig. 3. Western blot analysis of multiple human alcoholic hepatitis (AH), alcoholic cirrhosis 
(AC), and normal (N) liver tissue samples. Protein extracts were analyzed for the presence of Id1 
and there was one extra visible band in AH patients that was not seen in the other experimental 
groups. Numbers on the right of the molecular ladder correspond to molecular weight in kDa. 













Chapter 1: A Review of Alcoholic Liver Disease and Introduction to Id1 
Alcohol’s Impact 
The excessive consumption of alcohol is a healthcare concern that accounted for 3 
million deaths worldwide in 2018.1 The effects of drinking to this degree are imprinted 
throughout a person’s body due to alcohol’s damage-inducing properties on all of the body’s 
organ systems. Due to alcohol’s effect on the consumer’s psychological state, drinking may also 
indirectly cause a slew of dangerous behaviors. In a 40-year systematic meta-analysis of 
literature pertaining to alcohol’s impact on gun violence it was found that in firearm homicides 
in the United States reported, 37% of the people that died had drank some amount of alcohol 
while 30% had drank a heavy amount of alcohol. Similarly, in firearm suicides 35% of decedents 
drank some amount of alcohol while 25% drank a heavy amount of alcohol.2 Alongside the 
staggering mortality, chronic alcohol consumption has been implicated in draining the economy. 
A study from the CDC estimated that in 2010 the economic cost was close to $250 billion in the 
United States.3 It was noted that these numbers would have increased still if the United States 
had not been in recovery from the recession from 2007-2009. 
 
Alcohol Metabolism  
Ethanol is metabolized in the main parenchymal cells of the liver (hepatocytes) which 
account for 70 percent of the liver’s mass.4 The hepatocyte’s chief alcohol metabolizing enzymes 
are alcohol dehydrogenase (ADH) and cytochrome P450 2E1 (CYP2E1). ADH is the more 
catalytically efficient enzyme, using NAD+ as a cofactor generating NADH and acetaldehyde as 
byproducts. Acetaldehyde is highly toxic and reactive but is very quickly metabolized into 
acetate by aldehyde dehydrogenase 2 (ALDH2) inside the mitochondria. This reaction also 
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generates NADH which, when taken together with ADH, can lead to an imbalance in the 
intrahepatic ratio of NAD+/NADH (the cellular redox potential). Drastic changes in the cellular 
redox potential can switch the oxidative metabolism in the liver towards reductive synthesis 
which causes the formation of fatty acids in the liver.5 Although CYP2E1 has a catalytic 
efficiency much lower that ADH, it has a 10-fold higher capacity for binding ethanol. Ethanol 
directly interacts with the CYP2E1 protein which causes a conformational change that resists 
degradation, making this enzyme inducible.6 While this may be beneficial for the metabolism of 
alcohol, it leads to metabolic tolerance in heavy drinkers–they need to consume more alcohol to 
have the same intoxication level they had previously.  
 
Alcoholic Liver Disease 
Chronic alcohol consumption leads to a spectrum of conditions collectively known as 
Alcoholic Liver Disease (ALD). The diagnosis for ALD is determined by an established history 
of heavy alcohol consumption along with physical and laboratory examinations proving that the 
individual has associated liver disease.7 Due to the prerequisite of habitual drinking and patient’s 
reluctance to admit such behaviors, ALD is often times not diagnosed. Regardless, each stage 
has a distinct physiological presentation that can be observed through microscopic analysis of 
liver tissue sections. In steatosis, liver cells accumulate lipid droplets which can be seen 
histologically as empty bubbles in their cytoplasm. Alcoholic hepatitis or steatohepatitis present 
through tissue damage usually seen as ruptures in the tissue or through invasion of immune cells 
into the liver with a predominance of neutrophils. Fibrosis and its terminal stage cirrhosis are 
characterized by many thin long cellular projections known as fibroblasts that surround circular 
patches of functional hepatocytes. The main recommendation for treatment in these diseases is 
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abstinence. Due to the addictive nature of alcohol, though, this treatment is hard to implement 
outside of a healthcare setting. For alcoholic hepatitis, corticosteroids or other drugs that aim to 
curtail the immune system have been implemented; however, these drugs have failed to prove 
clinically significant increases in survival.8 Transplantation is another option for the treatment of 
end stage liver disease. 
 
Steatosis  
The most common and earliest stage observed among problem drinkers is steatosis or 
fatty liver disease; this stage develops in more than 90 percent of problem drinkers and can be 
developed following binge drinking.9 Steatosis is characterized by the deposition of fat, seen 
histologically as lipid droplets in hepatocytes. Initially these lipid droplets are seen in the 
hepatocytes surrounding the liver’s central vein, but as alcohol consumption continues, these 
lipid droplets can be observed in mid-lobular hepatocytes and those surrounding the hepatic 
portal vein.10 As mentioned previously, changes in the cellular redox potential in the liver leads 
to reductive synthesis which enhances lipogenesis. However, reductive synthesis does not 
account for the accumulation of fat within the liver. A growing body of research points to 
multiple mechanisms in the development of fatty liver disease.5,9  
In line with reductive synthesis, there are other mechanisms that occur in the liver 
following alcohol consumption which lead to enhanced lipogenesis. One such mechanism is the 
expression of lipogenic enzymes. Researchers have noted that the transcription factor family, 
sterol regulatory element-binding proteins (SREBPs), contributes to the accumulation of fat in 
the liver. These transcription factors regulate lipid synthesis and cholesterol by inducing the 
expression of more than 30 genes in the liver.11 In abstinent populations, these transcription 
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factors are fairly dormant in the liver; however, when one consumes alcohol heavily, the inactive 
form of these transcription factors, which are normally bound to the nuclear envelope or ER, can 
undergo processing which allows for the protein to traffic to the nucleus. Once this protein is in 
the nucleus, it can lead to the transcription of lipogenic enzymes, enhance fatty acid synthesis, 
and accelerate the accumulation of fat in the liver. Another transcription factor that has been 
implicated in the acceleration of triglyceride accumulation in the liver is Early growth response-1 
(Egr-1). Egr-1 has been established to bind the promoter region of stress-induced genes. One 
important gene influenced by Egr-1 is tumor necrosis factor-α (TNF- α).12 In the context of 
steatosis, TNF-α is considered a lipogenic cytokine due to inducing the maturation of SREBP-1.  
Once the lipid droplets have been established in the liver, hepatocytes need to degrade 
them in order to reverse steatosis. In order to break down lipid droplets, liver cells undergo a 
process known as lipophagy: fatty droplets are engulfed in a double membrane bound vacuoles 
termed the autophagosomes, the autophagosomes are trafficked to lysosomes where they fuse, 
lipases breakdown the triglycerides in the lysosomes, and the free fatty acids can be oxidized in 
the mitochondria. Chronic alcohol consumption is known to perturb this process at a few 
different points. Heavy alcohol consumption can lead to faulty biogenesis of lysosomes, resulting 
in fewer and defective lysosomes.13 Moreover, the generation of NADH during ethanol oxidation 
inhibits fatty acid breakdown in the mitochondria. Ethanol oxidation also depolarizes the 
mitochondria, impairing it’s ATP-generating function and leads to a leaky outer membrane.14 






Alcoholic Hepatitis  
The effects of fatty liver disease can be reversed by simply abstaining from drinking 
alcohol. However, if consumption continues the disease will progress to alcoholic hepatitis. 
Alcoholic hepatitis is an inflammatory-type disease with a 28-day mortality ranging from 30% -
50%.15 The diagnosis for this disease includes both a physical examination and verification 
through laboratory data. During physical examinations, common clinical manifestations include 
malnourishment, low blood pressure, tachycardia, jaundice, and with an enlarged, tender liver. 
Laboratory tests seek to determine levels of bilirubin, sodium, albumin, and white blood cells 
which have a neutrophilic predominance.15  
The pathophysiology in the liver is characterized by the swelling and death of 
hepatocytes, neutrophil infiltration, and the development of aggregates of insoluble proteins 
known as Mallory-Denk bodies.16 While neutrophil infiltration is a common motif in alcoholic 
hepatitis, resident and serum macrophages are thought of as central to the development of the 
disease. Kupffer cells are the resident macrophage in the liver, they account for 15% of the 
liver’s biomass and 50% of the body’s macrophages.17 Macrophage polarization is important to 
the induction of an immune response in the liver; they have an M1 state which has been 
established as proinflammatory and an M2 state which is anti-inflammatory. The functional state 
macrophages occupy is determined by their microenvironment which is influenced by circulating 
growth factors, cytokines, pathogen associated molecular pattern, and damage associated 
molecular patterns.  
Nutrient-rich blood travels in a direct route from the intestine to the liver via portal 
circulation, and due to the extensive microbe profile of the gastrointestinal (GI) tract, countless 
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pathogens make their way to the liver. Consequently, Kupffer cells have developed tolerogenic 
properties that prevent from mounting an immune response in the face of circulating pathogens. 
For this reason, induction of an immune response in the liver requires a second challenge to 
synergize with excessive alcohol consumption.18 One such challenge arises from the GI tract. 
Animal studies confirmed that chronic alcohol consumption leads to overgrowth of bacteria via 
direct and indirect mechanisms in the GI tract.19 Furthermore, this dysbiosis is accompanied by 
increased permeability in the gut epithelium. Maintenance of the epithelium in the gut is 
immunologically important as it functions as a barrier between us and the environment. It was 
shown in patients with alcohol dependence that their gut was permeable enough to allow large 
macromolecules through the intestinal barrier.20 One important macromolecule, in terms of 
alcoholic hepatitis, is endotoxin produced by gram-negative bacteria. This molecule is known to 
cause severe disease such as sepsis once in the circulation. In the liver, however, alcohol 
sensitized Kupffer cells can use their pattern recognition receptors to detect endotoxin. 
Engagement of these receptors, CD14 and TLR4, with their ligand results in the transcription of 
proinflammatory cytokines and subsequent activation of the immune cell. Once activated, 
Kupffer cells release these proinflammatory cytokines such as TNF-α, interleukins, chemokines, 
as well as produce reactive oxygen species that cause oxidative stress, and subsequently, the 
release of more cytokines.21  
The release of these factors into the liver has deadly consequences. Hepatocytes are 
normally immune to TNF-α, but after being sensitized by alcohol, these cells undergo apoptosis. 
Interestingly, the phagocytosis of apoptotic bodies by macrophages functions as an alternative 
mechanism that converts macrophages into their proinflammatory functional state.15 Chemokines 
released by Kupffer cells can be sensed by other immune cells in circulation such as 
 7 
lymphocytes and neutrophils, attracting them to the site of inflammation. Their effector functions 
in the liver synergize with the reactive oxygen species production from Kupffer cells and alcohol 
metabolism in general which exacerbates oxidative stress.  
 
Fibrosis  
Liver fibrosis is the result of chronic liver injury followed by abnormal deposition of 
extracellular matrix proteins. These proteins interfere with the architecture of the liver through 
forming fibrous scars, and the development of hepatocyte nodules is what characterizes the 
terminal stage of fibrosis–cirrhosis. Changes to the cellular architecture of the liver results in 
increased resistance to blood flow, hepatic insufficiency, and hypertension in the portal venous 
system.  Due to the insidious nature of this disease, diagnosis and appropriate scaling of fibrosis 
is of paramount importance. In this regard, biopsies of liver tissue remain the golden standard; 
however, there are limitations to this approach. Biopsies are an invasive procedure that leads to 
pain and major complications in 40% and 0.5% of cases, respectively.7 Correctly characterizing 
the disease relies upon the features of the sample obtained, and therefore, there is a risk 
associated with sampling error or interobserver variation. While analyzing the concentrations of 
specific proteins such as N-terminal peptide of type III collagen or inhibitor of metalloprotease 
type 1 (TIMP-1) can offer a good indication of advanced cirrhosis or no fibrosis, they often times 
lack the ability to characterize intermediate levels of the condition reliably.7  
Hepatic stellate cells exhibit the secretion of extracellular matrix components into the 
liver. Under normal physiological conditions, hepatic stellate cells are storage sites for vitamin A 
and lie dormant within the space of Disse, the space in between hepatic sinusoids and the liver 
parenchyma. During hepatitis, Kupffer cells secrete signals, namely PDGF, which activate 
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quiescent hepatic stellate cells. Activated hepatic stellate cells transdifferentiate toward 
myofibroblast-like cells and contribute to the inflammatory response by secreting more 
chemokines, cytokines, and adhesion factors that attract immune cells from the periphery.22 
Attracted leukocytes target hepatocytes while also activating more stellate cells, leading to a 
positive feedback loop. At the resolution of inflammation, Kupffer cells release anti-
inflammatory cytokines such as prostaglandin D2 which stimulates the wound healing, extra 
cellular matrix deposition by hepatic stellate cells.17 The accumulation of extracellular matrix 
components is mediated by increased secretion and decreased breakdown. Breakdown of the 
ECM by matrix metalloproteases is stifled by the increased expression of their inhibitors 
(TIMPs) during fibrosis.23 
 
Inhibitor of Differentiation  
The helix-loop-helix (HLH) transcription factors are a large family of proteins that rely 
primarily on their highly conserved HLH domains for protein-protein interactions. Their HLH 
domain consists of two amphipathic α-helices connected by a loop and gives these proteins the 
capability to homo- or heterodimerize with other HLH proteins in order to influence gene 
expression. The resulting fold between dimers is a non-covalent, parallel, left-handed four-helix 
bundle and in basic (b)HLH dimers this conformation forms a tweezer-like structure which is 
ideal for DNA binding.24 Class V HLH proteins are unique in that they lack a DNA-binding 
motif; consequently, these proteins sequester class I and II bHLH proteins, forming non-DNA 
binding dimers and act as dominant negative regulators of bHLH-mediated gene expression. 
There are a few pathways that lead to the expression of Id1, the most notable being the bone 
morphogenic protein (BMP) and nuclear factor Y complex (NFY-c) signaling pathways.24 BMPs 
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are a subgroup of the TGFβ superfamily and multiple have been implicated in the expression of 
Id1.25 Once a BMP protein interacts with its corresponding receptor (Type I, Type II, and co-
receptor Endoglin), the cytoplasmic tail of the receptor becomes phosphorylated. This 
phosphorylation event leads to autophosphorylation amongst the receptors which attracts and 
phosphorylates the SMAD1/5/8 complex. This phosphorylated complex can bind SMAD4, 
allowing the complex to localize to the nucleus where it can bind, amongst other regions, the 
promoter of Id1 and positively induce expression. The NFY-c binds to the CCAAT box on the 
promoter of Id1 which was shown to induce expression of the protein. In the NTera2 human 
embryonic cell line, NFY-promoter interaction decreased as retinoic acid causes differentiation 
in the cell.24 This could be attributed to the loss of NFY-c at the protein level as the cell 
differentiates.  
 
Id1 and The Cell Cycle  
One key set of Id1 binding partners, from which the protein received its name, are Cdk 
inhibitors. Id proteins antagonize the induction of gene expression in differentiation-associated 
genes such as p15, p16, and p21.24 The expression of these Cdk inhibitors is tied to bHLH 
proteins which can dimerize with Id1, leading to regulation of the cell cycle in the G1 phase. 
Crosstalk between p53 and Id1 has been reported as well: Id1 impairs the p53-mediated response 
to DNA damage while p53 upregulates the bHLH transcription factor DEC1 that downregulates 
Id1.24 This crosstalk has been implicated in the regulation of cell-cycle arrest and senescence 




Chapter 2: Increased Expression of Id1 in Alcoholic Hepatitis Liver Samples 
2.1 Introduction  
The excessive consumption of alcohol is a healthcare concern that accounted for 3 
million deaths worldwide in 2018.1 Among people between the ages of 20 and 39, approximately 
13% of deaths were attributable to alcohol consumption.1 The damaging effects of alcohol on the 
liver lead to the development and progression of Alcoholic Liver Disease (ALD). Progression 
through ALD revolves around the histological changes of hepatocytes as a result of constant 
alcohol exposure. The most common and earliest stage observed among problem drinkers is 
steatosis; this stage develops in more than 90 percent of problem drinkers and can be developed 
following binge drinking.9 Steatosis is characterized by the deposition of fat, seen histologically 
as lipid droplets in hepatocytes. Initially these lipid droplets are seen in the hepatocytes 
surrounding the liver’s central vein, but as alcohol consumption continues, these lipid droplets 
can be observed in mid-lobular hepatocytes and those surrounding the hepatic portal vein. 
Steatosis can be reversed if alcohol consumption ceases; however, increased exposure to alcohol 
in the liver leads to alcoholic steatohepatitis which is characterized by the swelling and death of 
hepatocytes, neutrophil infiltration, and the development of aggregates of insoluble proteins 
known as Mallory-Denk bodies. In this stage liver damage is inflicted by the activation of the 
immune system, namely Kupffer cells, the resident macrophages in the liver. During 
steatohepatitis, these cells are found to secrete cytokines that not only kill hepatocytes, but also 
recruit more immune cells to infiltrate the liver. Fibrosis and its terminal stage cirrhosis refer to 
scaring of the liver tissue. These stages are characterized by the unusual deposition of 
extracellular matrix proteins.   
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There is evidence of crosstalk between different hepatic cell types during the 
pathogenesis of alcoholic hepatitis and fibrosis.22 Hepatic stellate cells reside in a quiescent state 
in the space of Disse, the space between the liver parenchyma and sinusoid, and function as a 
major storage site for vitamin A. Under inflammatory conditions, these cells are known to 
transmit proinflammatory cytokines in response to stimulation from the sinusoid resulting in 
amplification of inflammation. At the resolution of an inflammatory response, Kupffer cells 
release prostaglandin D2, an anti-inflammatory cytokine, which stimulates a wound healing, 
fibrogenic response in hepatic stellate cells.17 This wound healing response is characterized by 
transdifferentiation of the stellate cell towards a myofibroblast-like cell morphology and 
abnormal secretion of extracellular matrix proteins. It has been reported that an increase in 
inhibitor of DNA binding 1 (Id1) is accompanied by the transdifferentiation of hepatic stellate 
cells.17  
Id1 is a class V helix-loop-helix (HLH) protein, and unlike basic (b)HLH proteins, Id1 
lacks an N-terminal associated DNA-binding domain. HLH proteins function as important 
regulators of gene expression. (b)HLH proteins rely on non-covalent interactions between their 
HLH motifs for homo- and heterodimerization, and if the two conjoined proteins contain DNA-
binding domains, this quaternary protein structure forms a tweezer-like structure which allows 
the protein to bind DNA and influence gene expression. Since Id1, along with other class V HLH 
proteins, do not contain DNA-binding domains, they function as dominant negative inhibitors of 
HLH-regulated gene expression. An increase in Id1 is known to play an important role in many 
different cellular processes in liver cells including liver regeneration, dedifferentiation of hepatic 
cancer cells, and fibrogenesis.4, 26 Although previous reports have found increases in the 
expression of Id1 correlated to hepatic injury models such as hepatitis C virus27, hepatitis B 
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virus28, and hepatocellular carcinoma29, this trend has not been evaluated in alcoholic liver injury 
models. In this paper, we show that there is an increase in the expression of Id1 correlated with 
alcoholic hepatitis. This information not only validates that Id1 is a commonly induced gene 
during hepatic injury, but it also may shed some light into the crosstalk between nonparenchymal 




To determine the expression of Id1 in both normal and alcoholic hepatitis (AH) liver tissues, we 
used immunohistochemical staining. Human donor and AH liver tissues were collected during 
liver transplantation and stored in formalin for 3 days. These samples were then processed, 
embedded in paraffin wax, cut into 4 μm sections, and mounted on positively charged slides. The 
sections were incubated with a rabbit monoclonal antibody against Id1 in a dilution of 1:250. 
There is also uncertainty that the monoclonal antibody that is used for these experiments targets 
only what we intend it to; therefore, we used an isotype of our antibody (IgG2a) to determine 
specificity. More 4 μm sections of the same samples were cut and incubated with IgG2a for 
comparative analysis.  
 
SDS-PAGE and Western Blot  
Western blots were used to determine the amount of Id-1 present in different liver tissues. 
Normal donor, AH, and alcoholic cirrhosis (AC) liver tissues were homogenized and centrifuged 
to isolate proteins. The protein concentration from each protein lysate was standardized using the 
BioRad DC Protein Assay. Five microliters of each protein lysate were separated in denaturing 
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conditions using BioRad Mini-PROTEAN® TGX 10% gels. Separated proteins were transferred 
to a nitrocellulose membrane using polyacrylamide gel electrophoresis (PAGE). The membrane 
was washed using distilled water before incubating in TBS-T/10% BSA for 30 minutes. 
Following incubation in the blocking buffer, the mouse anti-Id1 monoclonal antibody was added 
into the blocking solution in a 1:500 dilution and stored overnight on a rocker in -4 °C. The next 
day, the primary antibody was removed and washed three times with TBS-T for five min per 
wash. The membrane was then incubated in anti-mouse secondary antibody in a 1:5000 dilution 
for one hour. Following three more washes, the membrane was visualized using enhanced 
chemiluminescence substrate.  
 
Immunoprecipitation 
In order to isolate and analyze our protein of interest we will use the Pierce Crosslink Magnetic 
IP/Co-IP Kit (Thermo Scientific). To begin, we incubated rabbit anti-Id1 monoclonal antibodies 
with magnetic beads at a dilution of 10 μg per 100 μL for 15 min. Following washes to remove 
unbound antibodies, we incubated the antibody bound beads with a DSS crosslinker (10X molar 
excess relative to beads) for 30 min. Following purification, we stored the beads in a 4 °C. 
Human donor and AH liver samples were homogenized and centrifuged in order to obtain a 
protein lysate. We used the BioRad DC Protein Assay to standardize protein concentrations 
among the different samples. We incubated 500 μL of diluted lysate with crosslinked beads for 1 
hour at room temperature. The proteins were then isolated by washing the beads with elution 
buffer and collecting the beads with a magnetic stand, separating the remaining liquid. We then 
ran more SDS-PAGE and Western Blot to confirm that our protein of interest was present in the 
bound antigens.  
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2.3 Results 
Increased Id-1 Expression During Liver Damage 
Following incubation with a rabbit monoclonal antibody against the protein Id-1, healthy donor 
tissue (termed normal. Fig. 2.) showed modest staining. This suggests that during normal 
physiological conditions, the liver does not express much of the Id-1 protein. Incubation with the 
same monoclonal antibody in alcoholic hepatitis liver samples shows visibly increased tissue 
staining. This illustrates that during chronic liver damage, the cells of the liver parenchyma 
(hepatocytes) change their expression profile to translate more of the Id-1 protein.  
 
Altered Id-1 Protein Structure 
Western blot analysis of healthy human donor liver tissues showed that the majority of the Id-1 
protein was around 50 kDa (Fig. 3.). In other experimental groups, alcoholic hepatitis and 
alcoholic cirrhosis, a band at this size was present. While there may be differences in tissue 
staining between donor and alcoholic hepatitis groups, there is some commonality observed in 
protein size. However, in the alcoholic hepatitis group, there was another band present that was 
not present to the same extent in other groups. This band was observed at around 25 kDa which 
may suggest protein dimerization, a common conformation found amongst the bHLH proteins. 
The western blot was carried out under reducing conditions, though, which eliminates the 
possibility of non-covalent protein interactions. The predicted weight of the Id-1 protein is 
around 16 kDa which suggests that there may be some covalent modification that is slowing the 
migration of this protein, leading to its appearance higher than expected on the membrane.  
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2.4 Discussion  
Further experimentation is required to confirm the protein structure of the different Id1 
bands. Due to the benign gel shift, though, we predict that it may be related to a mixture of post-
translational modifications to the protein, namely ubiquitination and phosphorylation. Moreover, 
we hypothesize that the observed increase in Id1 protein levels during alcoholic hepatitis is part 
of a stress response mechanism aimed at protecting liver cells from the oxidative stress caused 
by the inflammatory response.  
Id1 has been linked to a variety of cellular processes such as proliferation, regeneration, 
hematopoiesis, cell-cycle regulation and differentiation.30-32 The role of Id1 in other forms of 
hepatitis is somewhat controversial. One report described that hepatitis B viral components, such 
as its core and x proteins, are directly involved in destabilizing Id1 and reducing its transcription 
in the livers of mice.33 However, another publication shows that Id1 increases as hepatitis B viral 
protein x expression increases in immunohistochemical stains of human liver tissue.28 Increased 
Id1 expression was also reported in biopsies of liver tissues from patients with chronic hepatitis 
C viral infection.27 All of these papers share the conclusion that chronic infection with either 
virus leads to profibrogenic responses and hepatocellular carcinoma (HCC). 
Immunohistochemical staining of HCC tissue samples have consistently shown to express high 
levels of Id129; thus, increased expression of Id1 during infection with hepatitis virus is expected, 
as it is a common cause of HCC. Expression of Id1 in HCC has been linked to metabolic 
reprogramming of cancer cells through the regulation of c-Myc, leading to aerobic glycolysis and 
glutaminolysis.34 The expression of Id1 has also been reported in other liver cell types, 
conferring pro-fibrogenic responses in hepatic stellate cells.10 Wiercinska et. al. elucidated that 
ALK1/SMAD1 phosphorylation and subsequent Id1 expression was necessary for the 
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transdifferentiation of hepatic stellate cells to myofibroblasts. Myofibroblasts secrete matrix 
proteins into the liver, the characteristic sign of fibrosis. Altogether, our findings correspond with 
ongoing literature that Id1 is positively regulated in livers damaged through hepatitis. Whether 
the same result would be seen in the latter stages of ALD such as fibrosis, cirrhosis, or HCC 
requires further experimentation.  
 Interestingly, western blot analysis of Id1 protein in liver tissues harvested from patients 
with alcoholic hepatitis, alcoholic cirrhosis, and normal tissue revealed the presence of a band 
corresponding to a lower molecular weight in the alcoholic hepatitis experimental groups (Fig. 
2.). One key feature of the bands was the gel shift, there appeared to be multiple different bands 
observed. The western blot was conducted under reducing conditions which suggests that this 
shift may be caused by some covalent modifications. However, the molecular weight of the new 
band in the alcoholic hepatitis experimental group is closer to the predicted molecular weight of 
Id1. This suggests that the band corresponds to the removal of covalent modifications or 
unmodified Id1 protein. It has been reported that Id1, much like other regulators of the cell cycle, 
has a short half-life, being degraded by the 26S proteasome.35 Proteins that traffic to the 
proteasome can be poly-ubiquitinated or phosphorylated because these covalent modifications 
function as tags for proteasome-dependent degradation. We speculate that the band we observe 
in the alcoholic hepatitis experimental groups corresponds to unmodified Id1 protein. Thereupon 
Id1 may be afforded a longer half-life where it can carry out its dominant negative transcriptional 
suppression activity.  
 The most predominant form of cellular stress during alcoholic hepatitis (AH) is the 
increased oxidative burden placed upon hepatocytes. Before the induction of AH, liver cells 
sustain considerable changes to their redox potential due to the metabolism of alcohol. 
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Activation of Kupffer cells during AH leads to the production of reactive oxygen species (ROS) 
which increases oxidative stress. Moreover, release of cytokines by the liver’s resident 
macrophages stimulates the recruitment of other immune cells such as neutrophils and 
circulating macrophages whose effector functions lead to the production of more ROS. Aside 
from apoptosis, salvage mechanisms such as MAPK cascades become active in response to 
increased levels of ROS. The expression of early growth response-1 (Egr-1) has been 
documented as a downstream target of ERK1/2 pathway in response to oxidative stress.36 An 
Egr-1 consensus sequence has been identified in the promoter of Id137 and other studies have 
shown a positive correlation between Egr-1 and Id1 expression.38 Moreover, the expression of 
Id1 was shown to be increased in the pancreatic beta cell line MIN6 when cultured with H2O2. 
This increase in Id1 expression was also shown in vivo in the pancreatic cells of diabetic mice 
which was correlated with a global antioxidant response. When the researchers knocked out 
Id1/3, they observed a decrease in the expression of antioxidant enzymes and an increased level 
of ROS and apoptosis. These results led them to conclude that Id1 was, in fact, an important 
factor in the response to oxidative stress.39  
In conclusion, we hypothesize that increased ROS production during AH leads to the 
induction of Egr-1 which then stimulates the expression of Id1 in an attempt to protect cells from 
damage associated with increased oxidative burden. Id1 leads to cellular proliferation and the 
expression of antioxidant genes which make it an important regulator of oxidative stress. We 
believe that the increased Id1 protein levels are linked to the appearance of the lighter band in the 
western blots. Future studies should aim to assess the levels of ROS and antioxidant enzymes in 
Id1 knockout cell lines and mice in order to validate the proposed mechanism. The proposed Id1 
stress response mechanism has been shown to be true in other organ systems but has never been 
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validated in the liver. This evidence gives insight into the protective mechanisms of the liver 
which may provide useful information when studying other protective mechanisms such as the 
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